diabetic macular edema
diabetic macular edema
Explore linked clinical trials. Standard reference: MONDO:000472855 results · Page 1 of 3
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of RO7823653 in Participants With Diabetic Macular Edema (DME) | diabetic macular edema | Recruiting | Phase 1 | 2026-10-09 | NCT07425522 | |
| A Study to Evaluate Efficacy, Safety & Pharmacokinetics of the Port Delivery System (PDS) With Ranibizumab in Participants With Diabetic Macular Edema (DME) Compared With Intravitreal Ranibizumab; A Substudy to Evaluate the Safety of Re-implanting the PDS With Ranibizumab in Participants With DME | diabetic macular edema | Active, not recruiting | Phase 3 | 2026-10-08 | NCT04108156 | |
| COMO: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME | diabetic macular edema | Active, not recruiting | Phase 3 | 2026-10-02 | NCT07449936 | |
| CAPRI: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME | diabetic macular edema | Active, not recruiting | Phase 3 | 2026-10-02 | NCT07449923 | |
| A Real-World Study to Gain Clinical Insights Into Faricimab (FaReal Study) | diabetic macular edema | Active, not recruiting | Not stated | 2026-10-02 | NCT06680817 | |
| A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products | Branch Vein Occlusion, Embolism and Thrombosis, Venous Thrombosis, cardiovascular disorder, central retinal vein occlusion, diabetic macular edema, eye disorder, retinal disorder, retinal vein occlusion, thrombotic disease, vascular disorder | Active, not recruiting | Not stated | 2026-10-02 | NCT05476926 | |
| A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated | diabetic macular edema | Recruiting | Phase 1 / Phase 2 | 2026-09-30 | NCT07553429 | |
| Lactiplantibacillus Plantarum 299v Probiotic Supplementation in Patients With Diabetic Macular Edema | diabetic macular edema | Recruiting | Phase 2 | 2026-09-30 | NCT07383701 | |
| Speculum-Free Intravitreal Injection Using Cotton-Tipped Applicator Retraction: Pain, Procedure Time, Patient Satisfaction, and Safety | Embolism and Thrombosis, Metaplasia, Neovascularization, Pathologic, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Polypoidal Choroidal Vasculopathy, Venous Thrombosis, cardiovascular disorder, choroidal neovascularization, diabetic macular edema, eye disorder, optic choroid disorder, retinal disorder, retinal vein occlusion, thrombotic disease, uveal disorder, vascular disorder | Active, not recruiting | Not applicable | 2026-09-25 | NCT07481500 | |
| A Study Intravitreal THN391 in Diabetic Macular Oedema Secondary to Non-Proliferative Diabetic Retinopathy. | Diabetes Complications, cardiovascular disorder, diabetes mellitus, diabetic macular edema, diabetic peripheral angiopathy, diabetic retinopathy, endocrine system disorder, eye disorder, retinal disorder, vascular disorder | Recruiting | Phase 1 | 2026-09-21 | NCT06701721 | |
| A Phase 3b, Single-Arm Study of Aflibercept 8 mg Dosed Every 4 Weeks in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD) or Diabetic Macular Edema (DME) | diabetic macular edema | Active, not recruiting | Phase 3 | 2026-09-18 | NCT06491914 | |
| Changes in Intraocular Pressure After Intravitreal Injection | Embolism and Thrombosis, Venous Thrombosis, cardiovascular disorder, diabetic macular edema, eye disorder, ocular hypertension, retinal disorder, retinal vein occlusion, thrombotic disease, vascular disorder | Not yet recruiting | Not stated | 2026-09-17 | NCT07826286 | |
| Blepharoptosis After Repeated Intravitreal Anti-VEGF Injections: A Prospective Study | age-related macular degeneration, diabetic macular edema, eye disorder, eyelid disorder, macular degeneration, ptosis, retinal degeneration, retinal disorder | Not yet recruiting | Not stated | 2026-09-15 | NCT07821450 | |
| EC-104 Intravitreal Implant for the Treatment of Diabetic Macular Edema | diabetic macular edema | Active, not recruiting | Phase 1 / Phase 2 | 2026-09-15 | NCT06536491 | |
| A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of RO7497372 in Participants With Diabetic Macular Edema (DME) | diabetic macular edema | Active, not recruiting | Phase 1 | 2026-09-02 | NCT06847854 | |
| A Study to Investigate Faricimab Treatment Response in Treatment-Naive, Underrepresented Patients With Diabetic Macular Edema | diabetic macular edema | Active, not recruiting | Phase 4 | 2026-08-25 | NCT05224102 | |
| 4D-150 in Patients With Diabetic Macular Edema | Diabetes Complications, cardiovascular disorder, diabetes mellitus, diabetic macular edema, diabetic peripheral angiopathy, diabetic retinopathy, endocrine system disorder, eye disorder, retinal disorder, vascular disorder | Active, not recruiting | Phase 2 | 2026-08-21 | NCT05930561 | |
| Real World Evidence in China: Faricimab Use in Diabetic Macular Edema, Retinal Vein Occlusion, and Neovascular Age-Related Macular Degeneration (The Farseeing Study) | Embolism and Thrombosis, Venous Thrombosis, cardiovascular disorder, diabetic macular edema, eye disorder, retinal disorder, retinal vein occlusion, thrombotic disease, vascular disorder | Active, not recruiting | Not stated | 2026-08-10 | NCT06439576 | |
| South Asian Patients With Diabetic Macular Oedema Treated With Faricimab Assessing the Efficacy, Durability, and Safety (SEAFAR Study) | diabetic macular edema | Not yet recruiting | Phase 4 | 2026-08-07 | NCT07753616 | |
| Phase I Study to Assess the Safety and Efficacy of OCU200 for Center-Involved Diabetic Macular Edema (DME) | diabetic macular edema | Recruiting | Phase 1 | 2026-07-31 | NCT05802329 | |
| Home- vs Hospital-based Care of Anti-VEGF Treatment for Diabetic Macular Edema: Non-inferiority RCT | Diabetes Complications, cardiovascular disorder, diabetes mellitus, diabetic macular edema, diabetic peripheral angiopathy, diabetic retinopathy, endocrine system disorder, eye disorder, retinal disorder, vascular disorder | Recruiting | Not applicable | 2026-06-08 | NCT06610747 | |
| Effectiveness of Multidisciplinary Protocolised Interventions on IVT Non-adherence Rates | diabetic macular edema, eye disorder, macular degeneration, retinal degeneration, retinal disorder | Not yet recruiting | Not applicable | 2026-05-05 | NCT07567898 | |
| Clinical Study to Compare Efficacy and Safety of AVT29 and Eylea HD in Participants With Diabetic Macular Edema | diabetic macular edema | Recruiting | Phase 3 | 2026-04-30 | NCT07489131 | |
| A 3-month Study to Compare the Safety of ONS-5010 in Vials Versus Pre-filled Syringe in Subjects With Visual Impairment Due to Retinal Disorders | Embolism and Thrombosis, Venous Thrombosis, age-related macular degeneration, cardiovascular disorder, diabetic macular edema, eye disorder, macular degeneration, retinal degeneration, retinal disorder, retinal vein occlusion, thrombotic disease, vascular disorder, wet macular degeneration | Active, not recruiting | Phase 3 | 2026-04-22 | NCT05112861 | |
| Treat & Extend Versus Fixed Dosing With Faricimab for Management of Diabetic Macular Edema: A Pragmatic, Multi-center, Open-label, Randomized, Controlled Trial | diabetic macular edema | Active, not recruiting | Phase 4 | 2026-04-17 | NCT05610319 |